Unique ID issued by UMIN | UMIN000002377 |
---|---|
Receipt number | R000002919 |
Scientific Title | PEG-IFN-alfa2b/Ribavirin combination therapy for chronic hepatitis C patients with low platelet count: efficacy and safety |
Date of disclosure of the study information | 2010/04/28 |
Last modified on | 2013/02/25 20:13:15 |
PEG-IFN-alfa2b/Ribavirin combination therapy for chronic hepatitis C patients with low platelet count: efficacy and safety
PEG-IFN-alfa2b/Ribavirin combination therapy for CH(C) patients with low platelet count
PEG-IFN-alfa2b/Ribavirin combination therapy for chronic hepatitis C patients with low platelet count: efficacy and safety
PEG-IFN-alfa2b/Ribavirin combination therapy for CH(C) patients with low platelet count
Japan |
chronic hepatitis C
Hepato-biliary-pancreatic medicine |
Others
NO
Efficacy
Safety,Efficacy
Efficacy
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Peg-IFN-alfa2b/Ribavirin thrapy
20 | years-old | <= |
80 | years-old | > |
Male and Female
chronic hepatitis C
Platelet count over 50000/mm3, under 100000/mm3
contraindication of Peg-IFN/Ribavirin thrapy
100
1st name | |
Middle name | |
Last name | Shuichi Kaneko |
Kanazawa university
Graduate school of meicine
Takara-Machi, Kanazawa, Ishikawa, Japan
1st name | |
Middle name | |
Last name |
Kanazawa university
University hospital
s-kaneko@umin.ac.jp
Kanazawa university
Kanazawa university
NO
2010 | Year | 04 | Month | 28 | Day |
Unpublished
Completed
2009 | Year | 08 | Month | 25 | Day |
2009 | Year | 10 | Month | 01 | Day |
2013 | Year | 03 | Month | 01 | Day |
2009 | Year | 08 | Month | 25 | Day |
2013 | Year | 02 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002919